Prakash Raman's most recent trade in Black Diamond Therapeutics Inc was a trade of 5,526 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on June 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 2.33 per share. | 20 Jun 2025 | 5,526 | 22,519 (0%) | 0% | 2.3 | 12,876 | Common Stock |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 1.88 per share. | 21 Mar 2025 | 6,848 | 16,993 (0%) | 0% | 1.9 | 12,874 | Common Stock |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 5,150 | 10,145 (0%) | 0% | 2.5 | 12,875 | Common Stock |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 2,694 | 4,995 (0%) | 0% | 4.8 | 12,877 | Common Stock |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,301 | 2,301 (0%) | 0% | 5.0 | 11,459 | Common Stock |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
Black Diamond Therapeutics... | Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 61,100 | 61,100 | - | - | Stock Option (Right to Buy) |